These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23781519)

  • 1. A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.
    Wang J; He XD; Yao N; Liang WJ; Zhang YC
    Can J Gastroenterol; 2013 Jun; 27(6):351-63. PubMed ID: 23781519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.
    Zhu GQ; Shi KQ; Yu HJ; He SY; Braddock M; Zhou MT; Chen YP; Zheng MH
    Oncotarget; 2015 Jul; 6(20):18151-61. PubMed ID: 26061709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis.
    Wu J; Yin Z; Cao L; Xu X; Yan T; Liu C; Li D
    Medicine (Baltimore); 2018 Jul; 97(28):e11295. PubMed ID: 29995763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials.
    Zhong JH; Li H; Li LQ; You XM; Zhang Y; Zhao YN; Liu JY; Xiang BD; Wu GB
    Eur J Surg Oncol; 2012 Apr; 38(4):286-95. PubMed ID: 22281155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
    Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
    BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma: a systematic review and a meta-analysis.
    Lin HS; Wan RH; Gao LH; Li JF; Shan RF; Shi J
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):236-45. PubMed ID: 26063023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review.
    Zhong JH; Zhong QL; Li LQ; Li H
    Tumour Biol; 2014 Oct; 35(10):9459-68. PubMed ID: 25119592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhuang L; Zeng X; Yang Z; Meng Z
    PLoS One; 2013; 8(9):e61361. PubMed ID: 24069133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel systemic therapy options for hepatocellular carcinoma.
    Cusnir M; Patt YZ
    Cancer J; 2004; 10(2):97-103. PubMed ID: 15130269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A systematic review and meta-analysis of randomized controlled trails : adjuvant interferon therapy for hepatocellular carcinoma].
    Zhuang LP; Zeng XT; Meng ZQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):363-7. PubMed ID: 22971282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
    Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
    Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
    Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
    Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.
    Samuel M; Chow PK; Chan Shih-Yen E; Machin D; Soo KC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001199. PubMed ID: 19160192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma.
    Shimizu K; Kotera Y; Aruga A; Takeshita N; Katagiri S; Ariizumi S; Takahashi Y; Yoshitoshi K; Takasaki K; Yamamoto M
    Hum Vaccin Immunother; 2014; 10(4):970-6. PubMed ID: 24419174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.